KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Raw Materials (2016 - 2026)

Boston Scientific's Raw Materials history spans 18 years, with the latest figure at $928.0 million for Q1 2026.

  • On a quarterly basis, Raw Materials rose 10.08% to $928.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $928.0 million, a 10.08% increase, with the full-year FY2025 number at $849.0 million, up 3.66% from a year prior.
  • Raw Materials hit $928.0 million in Q1 2026 for Boston Scientific, up from $849.0 million in the prior quarter.
  • Over the last five years, Raw Materials for BSX hit a ceiling of $928.0 million in Q1 2026 and a floor of $499.0 million in Q1 2022.
  • Historically, Raw Materials has averaged $743.2 million across 5 years, with a median of $818.0 million in 2024.
  • Biggest five-year swings in Raw Materials: surged 41.09% in 2023 and later fell 1.65% in 2025.
  • Tracing BSX's Raw Materials over 5 years: stood at $548.0 million in 2022, then surged by 41.06% to $773.0 million in 2023, then grew by 5.95% to $819.0 million in 2024, then increased by 3.66% to $849.0 million in 2025, then increased by 9.31% to $928.0 million in 2026.
  • Business Quant data shows Raw Materials for BSX at $928.0 million in Q1 2026, $849.0 million in Q4 2025, and $849.0 million in Q3 2025.